Ignite Creation Date:
2024-05-06 @ 6:09 PM
Last Modification Date:
2024-10-26 @ 2:43 PM
Study NCT ID:
NCT05568680
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2022-09-28
Brief Title:
SynKIR-110 for Mesothelin Expressing Ovarian Cancer Cholangiocarcinoma or Mesothelioma
Sponsor:
Verismo Therapeutics
Organization:
Verismo Therapeutics
Organization Data
Organization:
Verismo Therapeutics
Class:
INDUSTRY
Study ID:
STAR-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Verismo Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None